Yescarta | search
Click here to view Yescarta news from 60+ newspapers.
Bookmark or Share- Axicabtagene ciloleucel - WikipediaAxicabtagene ciloleucel, sold under the brand name Yescarta, is a medication used for the treatment for large B-cell lymphoma that has failed conventional treatment. T cells are removed from a person with lymphoma and genetically engineered to produce a specific T-cell receptor.
- YESCARTA® (axicabtagene ciloleucel) Patient & Caregiver Site | CAR T ...YESCARTA® is a prescription medicine used to treat two types of non-Hodgkin lymphoma: large B-cell lymphoma when your first treatment did not work or your cancer returned within a year of first treatment, OR when at least two kinds of treatment have failed to control your cancer.
- YESCARTA® (axicabtagene ciloleucel) Treatment Process | Patient ...YESCARTA® is a prescription medicine used to treat two types of non-Hodgkin lymphoma: large B-cell lymphoma when your first treatment did not work or your cancer returned within a year of first treatment, OR when at least two kinds of treatment have failed to control your cancer.
- YESCARTA | FDA - U.S. Food and Drug AdministrationYESCARTA. STN: BL 125643. Proper Name: axicabtagene ciloleucel. Trade Name: YESCARTA. Manufacturer: Kite Pharma Inc. Indication: For the treatment of adult patients with large B-cell lymphoma...
- Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell ...The autologous anti-CD19 chimeric antigen receptor (CAR) T-cell therapy axicabtagene ciloleucel (axi-cel) is approved for the treatment of patients with relapsed or refractory large B-cell ...
More
